5-APB

1. 2026-10-19issueIssued info_card
2. 2026-09-24srcThe prevalence of new psychoactive substances in biological material - a three-year review of casework in Poland.
3. 2026-09-24srcCytotoxic effects of psychotropic benzofuran derivatives, N-methyl-5-(2-aminopropyl)benzofuran and its N-demethylated derivative, on isolated rat hepatocytes
4. 2026-09-24srcEmerging club drugs: 5-(2-aminopropyl)benzofuran (5-APB) is more toxic than its isomer 6-(2-aminopropyl)benzofuran (6-APB) in hepatocyte cellular models
5. 2026-09-24srcNeurochemical binding profiles of novel indole and benzofuran MDMA analogues
6. 2026-09-24srcThe psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats
7. 2026-09-24srcMetabolic fate, mass spectral fragmentation, detectability, and differentiation in urine of the benzofuran designer drugs 6-APB and 6-MAPB in comparison to their 5-isomers using GC-MS and LC-(HR)-MSn techniques
8. 2026-09-24srcIntoxication caused by new psychostimulants: analytical methods to disclose acute and chronic use of benzofurans and ethylphenidate
9. 2026-09-24srcAcute Toxicity Associated With the Recreational Use of the Novel Psychoactive Benzofuran N-methyl-5-(2 aminopropyl)benzofuran
10. 2026-09-24srcDiscriminative stimulus and locomotor effects of para-substituted and benzofuran analogs of amphetamine
11. 2026-09-24srcNeurochemical profiles of some novel psychoactive substances
12. 2026-09-24srcFatal intoxication with 3-methyl-N-methylcathinone (3-MMC) and 5-(2-aminopropyl)benzofuran (5-APB)
13. 2026-09-24srcA fatal blood concentration of 5-APB
14. 2026-09-24srcDeath following consumption of MDAI and 5-EAPB
15. 2026-09-24srcEffect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data?
16. 2026-09-24srcCombined in vitro and in silico approaches to the assessment of stimulant properties of novel psychoactive substances - The case of the benzofuran 5-MAPB
17. 2026-09-24srcMeasuring inhibition of monoamine reuptake transporters by new psychoactive substances (NPS) in real-time using a high-throughput, fluorescence-based assay.
18. 2026-09-24src(2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice
19. 2026-09-24srcCardiac Consequences Associated with Psychedelic Use: A Systematic Review of LSD, MDMA, and 5-HT2B-Mediated Valvular Heart Disease.
20. 2026-09-24srcPharmacological profile of novel psychoactive benzofurans
21. 2026-09-24srcNovel psychoactive benzofurans strongly increase extracellular serotonin level in mouse corpus striatum
22. 2026-09-24srcNeuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants
23. 2026-09-24src5-APB Wikipedia article: History, pharmacology, legal status
24. 2026-09-24srcDrugs Information - APB
25. 2026-09-24src5-APB (CID 9837232) — PubChem Compound Database
26. 2026-09-24srcCircular 008/2013: Temporary Class Drug Order on NBOMe and Benzofuran compounds
27. 2026-09-04issueIssued emergency
28. 2026-09-04issueIssued info_card
29. 2026-09-04issueIssued notice
30. 2026-06-04proposal30 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
31. 2026-06-04publicationPublication — backfill
32. 2026-04-28revisionRevision 1
33. 2026-04-28absenceSearched PubMed for "tramadol serotonergic drug interaction serotonin syndrome fatal; 5-APB hyperthermia clinical; Nichols MDMA alternative" — no results
34. 2026-04-28absenceSearched ClinicalTrials.gov for "5-APB benzofuranylpropylamine" — no results
35. 2026-04-28absenceSearched ClinicalTrials.gov for "5-APB benzofuranylpropylamine" — no results
36. 2026-04-28genGeneration — pipeline-v5 · with 2 morepipeline-v5
37. 2026-04-28rungeneration run

The same entries, as forms: six forms.